Device Trial Radar · NCT07714694
Consumer Evaluation of an Investigational Intermittent Catheter
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
68
Actual
Start
Jul 9, 2026
Primary completion
Nov 6, 2026
Study completion Nov 6, 2026
Sponsor
- Lead sponsor
- Hollister IncorporatedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 20, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Male only, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This clinical study is designed to evaluate the initial safety and performance of an investigational intermittent urinary catheter in people who use intermittent catheterization. Participants will use the study catheter and provide feedback on their experience, including ease of insertion, advancement through the urethra, bladder drainage, withdrawal, comfort, confidence, satisfaction, and overall ease of use. Safety will be evaluated through reported health changes and adverse events. Device performance and user experience will be assessed using participant questionnaires and comparisons with the participant's current intermittent catheter, including questions related to catheter handling, comfort during catheterization, perceived ability to empty the bladder, likelihood of future use, and product preference. The study is intended to generate descriptive information on the initial clinical use of the investigational catheter and to help characterize its safety, usability, comfort, satisfaction, and performance relative to participants' current intermittent catheter products.
Conditions
- Urinary Retention
- Neurogenic Bladder
Interventions
An intermittent urethral urinary catheter with a tip, tube and drainage eyeletsDevice
An intermittent urethral urinary catheter with a tip, tube and drainage eyelets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Health Changes and Adverse Events During Usual-Catheter and Investigational-Catheter UseTime frame: Through completion of both catheter-use periods, approximately 6 to 20 days
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hollister Incorporated
Libertyville, Illinois
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.